These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2864646)

  • 1. Effects of ketamine on the dynorphin levels and the ethylketocyclazocine (EKC) receptor binding in discrete regions of rat brains.
    Pongdhana K; Ogawa N; Hirose Y; Ohara S; Kosaka F; Tachibana S
    Neurochem Res; 1985 Jul; 10(7):945-52. PubMed ID: 2864646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynorphin A-(1-13)-Tyr14-Leu15-Phe16-Asn17-Gly18-Pro19 : a potent and selective kappa opioid peptide.
    Martinka GP; Jhamandas K; Sabourin L; Lapierre C; Lemaire S
    Eur J Pharmacol; 1991 Apr; 196(2):161-7. PubMed ID: 1678718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
    Devlin T; Shoemaker WJ
    J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological evidence for kappa-agonist activity of dynorphin in rat brain.
    Brookes A; Bradley PB
    Neuropharmacology; 1984 Feb; 23(2A):207-10. PubMed ID: 6325991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.
    Shearman GT; Schulz R; Schiller PW; Herz A
    Psychopharmacology (Berl); 1985; 85(4):440-3. PubMed ID: 2862651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for kappa 1 opioid receptor multiplicity in the guinea pig cerebellum.
    Kinouchi K; Pasternak GW
    Eur J Pharmacol; 1991 Jun; 207(2):135-41. PubMed ID: 1679014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S; Bhargava HN
    Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
    Nock B; Rajpara A; O'Connor LH; Cicero TJ
    Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tritiated ethylketocyclazocine binding in rat brain: differential distribution of binding sites across brain regions.
    Hewlett WA; Akil H; Carlini W; Barchas JD
    Life Sci; 1982 Sep 20-27; 31(12-13):1351-4. PubMed ID: 6128657
    [No Abstract]   [Full Text] [Related]  

  • 12. [3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain.
    Young EA; Walker JM; Lewis ME; Houghten RA; Woods JH; Akil H
    Eur J Pharmacol; 1986 Mar; 121(3):355-65. PubMed ID: 2870933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal depletion of hypothalamic dynorphin in anorexic Walker-256 tumor-bearing rats.
    Steele TD; Bryant HU; Malven PV; Yim GK
    Pharmacol Biochem Behav; 1988 Mar; 29(3):541-5. PubMed ID: 2896361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of rat globus pallidus neurons to microintophoretically applied mu and kappa opioid receptor agonists.
    Huffman RD; Frey JM
    Eur J Pharmacol; 1989 Nov; 170(3):179-91. PubMed ID: 2575994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H] dynorphin binding to guinea pig and rat brain.
    Young E; Walker JM; Houghten R; Akil H
    Life Sci; 1983; 33 Suppl 1():287-90. PubMed ID: 6141490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential time course of effects of kappa-opioid agonist treatment on dynorphin A levels and kappa-opioid receptor density.
    D'Addario C; Di Benedetto M; Izenwasser S; Candeletti S; Romualdi P
    J Mol Neurosci; 2004; 24(2):307-14. PubMed ID: 15456944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
    Knox RJ; Dickenson AH
    Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for isolation of kappa-opioid binding sites by dynorphin affinity chromatography.
    Simon J; Benyhe S; Hepp J; Varga E; Medzihradszky K; Borsodi A; Wollemann M
    J Neurosci Res; 1990 Apr; 25(4):549-55. PubMed ID: 1972199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis.
    Fischel SV; Medzihradsky F
    Neuropharmacology; 1986 Apr; 25(4):351-9. PubMed ID: 3012397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.